
PetIQ PETQ
Annual report 2023
added 02-29-2024
PetIQ ROCE Ratio 2011-2025 | PETQ
Annual ROCE Ratio PetIQ
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.46 | -3.01 | 2.2 | -0.48 | 0.7 | 2.56 | 10.83 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.83 | -3.01 | 2.61 |
Quarterly ROCE Ratio PetIQ
| 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.67 | -3.49 | -3.93 | 1.92 | 2.59 | 2.77 | 2.27 | 2.22 | 0.56 | 0.13 | -1.98 | -2.21 | -1.27 | -0.52 | 0.46 | 2.79 | 3.36 | 1.8 | 2.96 | 2.8 | 6.18 | 10.83 | 10.97 | 6.91 | 1.47 | -2.44 | -2.61 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.97 | -9.67 | 1.29 |
ROCE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Canopy Growth Corporation
CGC
|
-24.04 | $ 1.69 | -3.16 % | $ 182 M | ||
|
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | ||
|
Assertio Holdings
ASRT
|
-176.47 | $ 0.73 | -3.54 % | $ 51.9 M | ||
|
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
-190.63 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | ||
|
Cronos Group
CRON
|
-10.43 | $ 3.05 | -6.72 % | $ 1.63 B | ||
|
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | ||
|
Aurora Cannabis
ACB
|
-23.09 | $ 5.17 | -4.22 % | $ 86.3 M | ||
|
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
-39.6 | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
-85.61 | - | 2.45 % | $ 38.1 M | ||
|
DURECT Corporation
DRRX
|
-249.5 | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | ||
|
Organogenesis Holdings
ORGO
|
-0.49 | $ 4.78 | -0.83 % | $ 629 M | ||
|
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M | ||
|
Emergent BioSolutions
EBS
|
-111.87 | $ 12.03 | 5.34 % | $ 616 M | ||
|
Pacira BioSciences
PCRX
|
-9.43 | $ 26.7 | 1.56 % | $ 1.23 B | ||
|
Evoke Pharma
EVOK
|
-184.26 | $ 10.97 | 0.18 % | $ 36.7 M | ||
|
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | $ 21.39 | 0.14 % | $ 2.04 B | ||
|
Rockwell Medical
RMTI
|
-31.33 | $ 0.87 | -5.71 % | $ 20.3 M | ||
|
Evolus
EOLS
|
-623.16 | $ 7.18 | 1.92 % | $ 445 M | ||
|
Harrow Health
HROW
|
0.61 | $ 45.82 | -2.64 % | $ 1.49 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
-84.11 | $ 3.51 | -2.11 % | $ 4.36 M | ||
|
China Pharma Holdings
CPHI
|
-59.23 | $ 1.55 | -0.26 % | $ 27.1 M | ||
|
Bausch Health Companies
BHC
|
-94.23 | $ 6.88 | -0.65 % | $ 2.51 B | ||
|
Veru
VERU
|
-114.23 | $ 2.44 | 0.83 % | $ 329 M | ||
|
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
-35.84 | $ 1.8 | -6.51 % | $ 402 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
-8.06 | $ 3.05 | 20.47 % | $ 42.9 M | ||
|
cbdMD
YCBD
|
-235.96 | $ 1.39 | 13.52 % | $ 5.99 M | ||
|
Neoleukin Therapeutics
NLTX
|
-29.88 | - | - | $ 193 M | ||
|
Solid Biosciences
SLDB
|
-81.9 | $ 5.81 | -1.11 % | $ 237 M | ||
|
Relmada Therapeutics
RLMD
|
-121.49 | $ 4.32 | 6.4 % | $ 130 M | ||
|
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | ||
|
Perrigo Company plc
PRGO
|
1.31 | $ 12.86 | -2.17 % | $ 1.77 B | ||
|
ProPhase Labs
PRPH
|
32.97 | $ 0.12 | 0.17 % | $ 1.9 M | ||
|
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | ||
|
Sundial Growers
SNDL
|
-68.48 | $ 1.96 | -11.31 % | $ 3.37 M | ||
|
OptiNose
OPTN
|
26.27 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | ||
|
SCYNEXIS
SCYX
|
99.6 | $ 0.64 | -1.25 % | $ 30.6 M | ||
|
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | ||
|
Tilray
TLRY
|
-41.31 | $ 11.6 | -4.56 % | $ 7.17 B | ||
|
TherapeuticsMD
TXMD
|
-29.1 | $ 1.69 | -3.43 % | $ 17.6 M | ||
|
Zomedica Corp.
ZOM
|
-13.16 | - | -0.21 % | $ 98 M | ||
|
Viatris
VTRS
|
7.66 | $ 11.66 | 0.09 % | $ 14.1 B |